Also known as Lys-Glu-Asp-Gly · KEDG tetrapeptide
Synthetic Lys-Glu-Asp-Gly tetrapeptide studied as a testis / reproductive-tissue bioregulator.
Research refreshed
Testagen is a synthetic tetrapeptide (Lys-Glu-Asp-Gly) in the Khavinson short-peptide bioregulator series, directed at reproductive (testicular) tissue and studied for effects on male reproductive and hormonal markers.
Testagen (Lys-Glu-Asp-Gly) is the reproductive-tissue member of the defined short-peptide bioregulator family — the synthetic, single-sequence counterpart to older testis extracts, framed around age-related decline in male reproductive function within the originating research tradition.
Reported research examined markers of testicular and reproductive function in models, consistent with the class hypothesis of tissue-selective transcriptional modulation. As with the rest of the series, the evidence is concentrated in one research tradition with limited independent replication, and it is not FDA-approved.
Proposed gene-regulatory modulation of gene expression in reproductive tissue.
Behind every vial of Testagen is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Testagen, specifically, is brought into being.
On paper, Testagen is C17H29N5O9 — about 447.4 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Assembling Testagen means roughly 4 coupling cycles on the synthesizer — one protected residue added at a time, which is also 4 chances for an incomplete coupling to seed a deletion impurity. It is a short sequence, which makes the build comparatively tractable — but short does not mean trivial, and purity is still won or lost downstream. It also carries a disulfide bridge, an extra step beyond a plain chain that adds both capability and cost.
The crude mixture — Testagen plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Testagen proves itself: identity confirmed by mass spectrometry against its ~447.4 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Testagen — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Testagen (Lys-Glu-Asp-Gly) is a tetrapeptide made by routine solid-phase synthesis with no disulfides or modifications, like the other Khavinson short peptides. Purity is governed by ordinary deletion-sequence and counterion control.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Recent clinical trials and publications mentioning Testagen, pulled automatically from ClinicalTrials.gov and PubMed and refreshed daily. Listings are unfiltered search results, not curated endorsements.
Testagen is a synthetic Lys-Glu-Asp-Gly tetrapeptide studied as a testis / reproductive-tissue bioregulator in the Khavinson short-peptide series.
Reproductive (testicular) tissue — each bioregulator in the series is framed around a specific target tissue.
It is concentrated in a single research tradition and is largely preclinical, so findings are preliminary. This page is a research and educational reference.
Synthetic tetrapeptide investigated for telomerase activity and circadian effects.
ViewThe natural pineal peptide bioregulator — the animal-derived counterpart to synthetic Epitalon, marketed for aging and telomere support.
ViewThymus-derived polypeptide complex — the founding tissue bioregulator (Cytomax) studied for immune restoration.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.